Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial

Table 5

Comparison of adverse events.

	All grade	Grade ≥3
Control group (n = 50)	18	7
Study group (n = 50)	20	12
χ2	0.772	2.316
	0.380	0.128